Health Economics and Outcomes Research

Value-Based Care through Comprehensive HEOR Solutions

At Navitas Life Sciences, Health Economics and Outcomes Research (HEOR) plays a pivotal role in bridging the gap between clinical trial outcomes and real-world patient experiences. By analyzing clinical data, economic projections, and real-world outcomes, our HEOR team helps pharmaceutical companies communicate the true value of their innovations. This comprehensive approach not only informs product lifecycle decisions—from development to market access and beyond—but also supports pricing and reimbursement strategies. With precision medicine and value-based care becoming increasingly important, HEOR in pharma has transitioned from a support function to a central component in pharmaceutical strategy, ensuring that new treatments deliver meaningful health improvements and economic value.

Evidence-Based HEOR Expertise

Our HEOR consulting services span the entire spectrum of drug development and commercialization. From identifying data gaps and developing budget models to crafting global value dossiers and preparing HTA submissions, our experts provide tailored solutions that meet the unique challenges faced by pharma, biotech, and medical device clients. We leverage systematic literature reviews, economic modelling, and patient preference studies to generate robust, evidence-based insights that enhance product value and support successful market entry and reimbursement negotiations. Powering possibilities in clinical and economic data to demonstrate the impact on patient outcomes and healthcare systems.

Image

HEOR consulting firms

Comprehensive HEOR Strategy and Evidence Development
Comprehensive HEOR Strategy and Evidence Development
Developing comprehensive roadmaps and evidence plans to support early product planning, including identifying data gaps, determining economic projections, and analyzing clinical trial data to demonstrate product value.
Literature Analysis and Review
Literature Analysis and Review
Performing thorough literature reviews on efficacy, safety, and economic aspects, as well as from published studies, to assess and support the value of products.
Clinical Outcomes Assessments
Clinical Outcomes Assessments
Designing and validating clinical outcome assessments (COAs), preparing necessary documents for regulatory submissions.
Global Economic Model Development
Global Economic Model Development
Creating economic models for Health Technology Assessment (HTA) and reimbursement processes, including collecting real-world data following product use.
Patient Choice and Utility Measurement
Patient Choice and Utility Measurement
Conducting discrete choice experiments and studies to measure utility, providing essential data for economic modelling and HTA submissions.
HTA Dossier Preparation and Strategic Advice
HTA Dossier Preparation and Strategic Advice
Offering scientific guidance and preparing HTA dossiers to enhance reimbursement and market access strategies.
Strategic Value Messaging
Strategic Value Messaging
Developing comprehensive value dossiers, materials for payer engagement, and toolkits to effectively communicate product value to stakeholders.
Alt Text

Key Services for Health Economics and Outcomes Research (HEOR)

  • Cost-Effectiveness & Economic Evaluation to analyze the economic value of interventions.
  • Budget Impact Modeling to assess the financial implications of new treatments.
  • Quality of Life Assessment to evaluate the impact of treatments on patient well-being.
  • Real-World Evidence (RWE) Generation for assessing treatment effectiveness and safety outside of clinical trials.
  • Economic Modeling & Statistical Analysis to predict outcomes and resource utilization.
  • Health Technology Assessment (HTA) to evaluate new health technologies.
  • Clinical Outcomes Assessment (COA) to measure treatment effectiveness and performance.
  • AI in HEOR for enhanced data analysis and predictive modeling.
  • Epidemiology Services to analyze disease distribution, causes, and effects.

Brochure

Alt Text

Real World Evidence (RWE) & Real-World Data (RWD) Services

Find out about our comprehensive RWD/RWE services and capabilities, including strategic planning, governance, operational support, and data coordination.

CASE STUDY

Alt Text

Successful Registry and Data Coordinating Center for Parkinson’s Foundation

Learn how we supported 90+ sites, Integrated nearly 2000 patients’ clinical with genetic data, and shared data sets with The Global Parkinson’s Genetics Program (GP2), and The National Institute on Aging (NIA)

ARTICLE

Alt Text

Technology-Enabled RWD in a Clinical Registry Ecosystem for Foundations

Published in: Applied Clinical Trials Online
Gain key insights on disease foundations' clinical registry ecosystem, technology-enabled RWD and clinical research data integration, Generative AI in healthcare, and more.

Extensive Experience in Managing Efficient Clinical Trials

0
Phase I-IV Clinical Trials
0
On-time
0
Years of Experience
0
Regulatory compliance

Gain the Navitas Life Sciences Edge

Global Presence

Global Presence

Expert support available in North America, EU, and Asia Pacific.
Diverse Experience

Diverse Experience

Handling phases I to IV and beyond.
Proven Benefits

Proven Benefits

Streamlined processes, reduced costs, optimized outcomes.
Tailored Solutions

Tailored Solutions

Customized support for unique trial needs.
350+ Clients

350+ Clients

Repeat business from 90% of clients with multiple years of engagement.

BLOGS

Alt Text

Advancing Patient-Centric Clinical Trials with Navitas Life Sciences

Patient-centric clinical trials, which are likely to be more efficient, productive, and engaging with patients and their needs, are at the forefront of Navitas Life Sciences' approach.  
Alt Text

Placing Patient Safety First: Preventing side effects and Medication interactions

Explore the significance of medication analysis, addressing crucial questions regarding potential adverse drug reactions and interactions.
Alt Text

Recognizing Patients' Wants and Needs for Patient Centricity and Enhanced Patient Engagement

Patient centricity has been at the heart of our clinical trials, as it is important to align with the needs and wants of patients to improve patient engagement during the trial. 

Get in touch

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us